The Efficacy and Safety of Endostatin Combined with Definitive Chemoradiotherapy for Unresectable Esophageal Squamous Cell Carcinoma: A Retrospective Analysis
A combination of endostatin with definite chemoradiotherapy in patients with unresectable esophageal squamous cell carcinoma achieved high response rates, progress-free survival rates, and overall survival rates. The toxicity was acceptable. Nevertheless, additional prospective randomized controlled clinical trials will be needed to confirm the superiority of this treatment strategy.
Authors
- Mengyuan Zhu (ORCID: https://orcid.org/0000-0001-6047-8557)
- Qun Li (ORCID: https://orcid.org/0000-0002-5501-8262)
- Xiaofen Pan
Institutions
- Sun Yat-sen University (CN)
- The Seventh Affiliated Hospital of Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Korean Journal of Gastroenterology
- Published
- 2025-10-24
- DOI
- https://doi.org/10.4166/kjg.2024.150
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sun Yat-sen University
- Sun Yat-sen University Cancer Center